Escherichia coli express fimbriae-associated adhesins through which they attach to mucosal cells and activate a cytokine response. The receptors for E. coli P fimbriae are the globoseries of glycosphingolipids; Galc~l--)4Gall3-containing oligosaccharides bound to ceramide in the outer leaflet of the lipid bilayer. The receptors for type 1 fimbriae are mannosylated glycoproteins rather than glycolipids. This study tested the hypothesis that P-fimbriated E. coli elicit a cytokine response through the release of ceramide in the receptor-bearing cell. We used the A498 human kidney cell line, which expressed functional receptors for P and type 1 fimbriae and secreted higher levels of interleukin (IL)-6 when exposed to the fimbriated strains than to isogenic nonfimbriated controls. P-fimbriated E. coli caused the release of ceramide and increased the phosphorylation of ceramide to ceramide 1-phosphate. The IL-6 response to P-fimbriated E. coli was reduced by inhibitors ofserine/threonine kinases but not by other protein kinase inhibitors. In contrast, ceramide levels were not influenced by type 1-fimbriated E. coli, and the IL-6 response was insensitive to the serine/threonine kinase inhibitors. These results demonstrate that the ceramide-signaling pathway is activated by P-fimbriated E. coli, and that the receptor specificity of the P fimbriae influences this process. We propose that this activation pathway contributes to the cytokine induction by P-fimbriated E. coli in epithelial cells.
U
ropathogenic Escherichia coli attach to uroepithelial cells and elicit a cytokine response in those cells (1) . The molecular mechanisms of attachment are well defined, but the transmembrane signaling events that lead to cytokine activation are not known (2) .
Attachment is mediated by fimbriae, bacterial cell surface organelles with lectin domains (2) . The lectins bind specifically to oligosaccharide epitopes exposed on cell surface glycoproteins or glycolipids. Type 1 fimbriae bind terminal mannose residues, S fimbriae recognize sialic acid determinants, and P fimbriae bind Galod--)4Gall3-containing oligosaccharides, the carbohydrate portion of the globoseries glycosphingolipids (3) (4) (5) (6) . Fimbriae enhanced the epithelial cell cytokine response to bacteria (7, 8) . P-fimbriated E. coli elicited a higher IL-6 response than isogenic strains lacking the fimbriae, and isolated P fimbriae with an intact lectin domain triggered an IL-6 response, whereas lectin-deficient fimbriae failed to do so (7) . Furthermore, cytokine activation was reduced by treatment that inhibited glycolipid receptor expression by the epithelial cells (9) .
These results suggested that fimbriae-glycolipid interactions may trigger transmembrane signaling events involved in the induction ofcytokine responses. The oligosaccharide receptor epitopes recognized by P fimbriae are bound to ceramide in the outer leaflet of the lipid bilayer (6, 10) . Until recently, glycolipids were not considered to participate in transmembrane signaling, partly because of the lack of a transmembrane domain. Recent studies have demonstrated that ceramide can be released from sphingomyelin (SM) 1 by agonists like TNF-cx, IL-113, or 1oL,25-dihydroxyvitamin D3 (11) (12) (13) . TNF-a-induced ceramide release has been shown to activate NF-gB (11) . Ceramide can also undergo phosphorylation through the action of membrane-bound serine/ threonine protein kinases, and ceramide 1-phosphate further activated IL-2 in thymoma cells (12, 14) .
The aim of this study was to examine if P-fimbriated E. coli activate the ceramide-signaling pathway, and if this can contribute to the induction of an epithelial cytokine response by these bacteria.
This study was presented in the preliminary form at the 8th International Congress of Mucosal Immunology, San Diego, July 1995 (abstract no. 503).
1Abb~viations used in this paper: cxMan, cc-methyl-D-mannoside; CAPK, ceramide~activated protein kinase; SM, sphingomyelin; SMase, sphingomyelinase. Bacteria. E. coli strains with defined P and type 1 fimbrial expression were used. E. coli AD110 was a clinical isolate from which the pap gene clusters, encoding P fimbriae, has been cloned and sequenced. E. coli HB101/papsD11o carried the plasmid pPIL110-35 with a 16-kb EcoR_I AD110 pap DNA insert in the EcoR.l site of pACYC184 (15) . E. coli PKL4 (AAEC film vc31) carried the plasmid pPKL4 with thefim DNA sequences from E. coli PC31 (t6). E. coli HB101 was pap negative but hybridized with probes for thefim DNA sequences. E. coli AAEC was pap andfim negative. Both strains were phenotypically negative for P and type 1 fimbriae. For adhesion testing and cytokine activation, E. coli AD110 was cultured on tryptic soy agar plates (TSA; Oxoid Ltd., Basingstoke, Hampshire, UK). E. coli HB101/pap~.D11O and E. coli PKL4 were cultured on TSA with tetracycline (10 I~g/ml) and ampillicin (100 Ixg/ml), respectively. Adhesin expression was tested by hemagglutination using human erythrocytes of blood group AlP1 and Ap erythrocytes as well as guinea pig erythrocytes (6) . P. fimbriae caused mannose-resistant agglutination of human AlP1 erythrocytes, which express the globoseries of glycolipids, but not ofAp erythrocytes, which lack these glycohpids (2, 5, 6) . Type 1 fimbriae caused mannose-sensitive agglutination of guinea pig erythrocytes that was inhibited by 0t-methyl-o-mannoside (etMan; 0.1 M) (3) .
Materials and Methods

Materials
Epithelial Cell Line. The human epithelial cell line A498 (HTB44, human kidney carcinoma; American Type Culture Collection) was grown in KPMI 1640 supplemented with 5% FCS, 1 mM sodium pyruvate, 1 mM nonessential amino acids, gentamicin (50 I~g/ml), and 2 mM L-glutamine. A stock culture was maintained in 75-cm 2 culture flasks (Falcon Labware, Becton Dickinson Ltd., Oxford, UK) at 37~ in a 5% CO 2 atmosphere and split weekly.
Bacterial Adherence Assay. A498 cells were detached by treatment with trypsin (0.25%) for 5 rain at room temperature or with 0.5 mM EDTA at 37~ for 15 rain, harvested by centrifugation at 150 g for 7 rain, and washed by repeated cycles of centrifugadon and resuspension in 60 mM PBS, pH 7.2. The epithelial cell suspension was mixed with bacteria (final concentration, 10 s cells and 109 bacteria/ml) and incubated for 45 rain at 37~ with endover-end rotation. Unattached bacteria were removed by repeated cycles of centrifugation and resuspension in PBS. The
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E. coli-induced Ceramide number of bacteria attached to 40 cells was counted by interference contrast microscopy (Nikon Microphot-FX; Nikon, Tokyo, Japan). Adherence is expressed as the mean number of attached bacteria per cell.
Cytokine Responses. The cytokine responses of A498 cells to the difference agonists were analyzed using cells grown to confluency in 24-well cell culture plates (Falcon). The medium was aspirated and replaced by fresh RMPI containing E. coli (108 bacteria/ml), PMA, (10 ng/ml), or SMase (0.01-1 U/ml). Bacterial multiplication was bruited by residual gentamicin.
The effect of protein kinase inhibitors on the cytokine response was tested by adding the inhibitors to the wells 10 rain before the agonist. Staurosporine and K252a (inhibitors of serine/ threonine kinases) were dissolved in 100% DMSO and diluted in R.PMI 1640 medium to a final concentration of 500 nM/well. Genistein and tyrphostin 51 (inhibitors of tyrosine phosphorylation) were dissolved in DMSO and diluted in 1LPMI 1640 to a final concentration of 10 p~M/well.
IL-6 Quantitation. This was by ELISA (17) . Briefly, mouse anti-human IL-6 mAbs (MS) (100 I~l/well, 5 I~g/rnl in 0.05 carbonate buffer, pH 9.8) were used for coating. Samples from the A498 cell line or rhlL-6 were diluted in PBS containing 1% BSA (1% BSA-PBS). Bound IL-6 was detected by addition of polyclonal rabbit anti-human IL-6 antibodies followed by goat antirabbit IgG alkaline phosphatase. The standard curve was prepared using stock rhlL-6. The activity of each sample was compared with the standard curve and given as picograms IL-6 per milliliter.
Glycosphingolipids. These were extracted from the A498 cell line as described (18, 19) . Cells were detached from the culture flasks into medium by mechanical scraping with a rubber policeman, collected by centrifugation at 150 g for 10 rain, and extracted with water/methanol (1:2) for 1 h at 65~ After centrifugation at 188 g for 10 min, the supernatant was collected, and the cell pellet was reextracted with methanol/chloroform (2:1). The supernatants from each extraction were pooled, and the solvents were removed by evaporation under nitrogen. The lipids were subjected to mild alkaline hydrolysis by 0.2 M KOH in methanol for 2 h at room temperature. After neutralization with acetic acid, the extract was adjusted to chloroform/methanol/water (1:I0:9) and desalted on a 3-ml C-18 Bond Elute column (Analytichem International Inc., Harbor City, CA). Desalted lipids were separated by TLC on Kieselgel 60 aluminium-backed HPTLC plates (Merck). The reference Glycolipid was globotetraosylceramide from human erythrocytes (20) .
Bacterial Binding to Glycolipids on TLC Plates. Bacterial binding to Glycolipids and Glycolipid extracts was studied by the TLC overlay assay (10, 21) . Bacteria were labeled by overnight growth in Luria broth containing 50 I~Ci of [3SS]methionine, harvested by centrifugation at 2,000 g for 10 rain, and resuspended in PBS to ~I09 bacteria/ml. The glycolipid extracts were run on TLC plates in chloroform/methanol/water (60:35:8). The plates were treated with 0.2% (wt/vol) polyisobutylmethacrylate in diethyl ether for 1 rain and dried at room temperature. To reduce nonspecific binding, the TLC plates were incubated with 2% BSA in PBS for 2 h. Without intermediate drying, the TLC plates were subsequently overlaid with the bacterial suspension and incubated for 2 h. Unbound bacteria were removed by extensive washing with BSA-PBS, and bound bacteria were detected by autoradiography.
Release and Phosphorylation of Ceramide. A498 cells labeled for 72 h with 75 }xCi/ml carrier-free 32p i or unlabeled A498 cells were detached with 0.25% of trypsin and washed in PBS. Cell pellets were resuspended in tLPMI 1640 to a final concentration of 0.3 • 106 cells/m] and exposed to bacteria (108 CFU/ml) or SMase (1.0 U/m]). Free ceramide and ceramide 1-phosphate were extracted as described (22) . Briefly, the reactions were terminated at given time points by lipid extraction of the cell pellets with 1 m] of chloroform/methanol/concentration HC1 (100:100: 1, vol/vol/vol) and 0.3 ml of balanced salt solution (BSS; 135 mM NaC1, 4.5 mM KC1, 1.5 mM CaC12, 0.5 mM MgC12, 5.6 mM glucose, 10 mM Hepes, pH 7.2) containing 10 mM EDTA. The organic phase was dried under N2, and lipids were subjected to mild alkaline hydrolysis by 0.1 M KOH in methanol at 37~ for 1 h. Extracts from unlabeled cells were then incubated with E. coli diacylglycerol kinase as described by Preiss et al. (23) . Ceramide 1-phosphate from this reaction as well from prelabeled cells was isolated by TLC using chloroform/methanol/acetic acid (65:15:5, vol/vol/vol). Authentic ceramide 1-phosphate (RF 0.25) was identified and quantitated by image analyzer (BAS 2000; Fuji Film, Tokyo, Japan). The levels of free ceramide from unlabeled cells are expressed as picomoles of ceramide 1-phosphate/106 cells. Levels of ceramide 1-phosphate in prelabeled cells are expressed as the percentage of the levels in labeled cells exposed to medium alone.
Assay of SMase Activity. [N-14CHa]choline-labeled milk SM (sp act 56 ~Ci/mg), synthesized by a demethylation-remethylation procedure (24) , was provided by Lena Nyberg (The Swedish Dairy Association, Lund, Sweden). SMase activity was measured according to Gatt (25) with modifications. 14C-SM stored in ethanol was dried under nitrogen and suspended in 0.15 M NaC1 containing 3 ~ bile salt mixture. Acid SMase activity was measured by adding 25 I~1 of samples and 0.1 ml of 14C-SM (40,000 dpm) in 375 ~1 50 m_M Tris-HC1 buffer containing 0.15 M NaCI and 3 mlM bile salt mixture, pH 5.0. Neutral SMase activity was assayed by adding the samples and 14C-SM to the same buffer supplemented with 2 ~ Mg a+ and 0.4% Triton X-100, pH 7.5. The incubation was performed at 37~ for 30 rain and terminated by addition of 2 ml chloroform/methanol (2:1, vol/vol). After centrifugation and phase partition, an aliquot of the upper phase was taken, and the radioactivity was determined by liquid scintillation counting. The activity was calculated and normalized as picomoles per hour per milligram protein.
Results
Fimbrial Expression and Cell Adhesion of the E. coli Strains.
E. coli AD110 expressed P fimbriae, but not type 1 tim-briae, under the culture conditions used in this study ( Table  1 ). The attachment to the A498 cells was inhibited by pretreatment o f the bacteria with the receptor analogue globotetraosylceramide (data not shown) but not by o~Man. The recombinant strain E. coli HBlO1/pap,~Dlt o expressed P fimbriae (Table 1 ). E. coli PKL4 expressed type 1 but not P fimbriae, and the attachment to A498 cells was inhibited by cxMan. E. coli HB101 and E. coli A A E C did not agglutinate erythrocytes or attach to epithelial cells. The E. coli strains attached in similar numbers to the A498 cell line and to exfoliated human uroepithehal cells (data not shown).
Bacterial Binding to Glycolipids on A 4 9 8 Cells. Glycohpids were extracted from the A498 cells and separated by TLC. Staining with anisaldehyde showed the presence o f glucosylceramides with three to seven sugar residues (not shown). Glycolipids with receptor activity for P fimbriae were detected by overlay with radiolabeled E. coli (Fig. 1) . E. coli HBlO1/papADllO recognized glycohpids in the tri-, tetra-, and heptaglucosylceramide regions o f the A498 extract and bound to the globotetraosylceramide control, but not to ceramide. The type 1-fimbriated strain E. coli PKL4 did not bind to the glycohpids on TLC. Neither did the nonfimbriated control strains E. coti HB101 or E. coli AAEC. 
coli AD110 (I-]), and E. coli HBlO1/pap/tol~ o (P fimbriated) (C)), E. coil HB101 (A), and E. coli AAEC (vector controls) ([])
. Means + SE l~om three separate experiments.
and 24 h. SMase induced a dose-dependent IL-6 response that was detectable above background by 2 h (1.0 U/ml, Table 2 ) and remained elevated after 6 and 24 h. At 0.01 U/ml, a response was detected only after 24 h. Cells exposed to SMase (1.0 U/ml) or E. coli ADll0 (108 CFU/ ml) secreted similar levels of IL-6 secretion. Costimulation of the cells with both agonists had an additive effect on the IL-6 response ( Table 2) .
Release of Ceramide in Cells Exposed to SMase or E. coli. The A498 cells were exposed to medium, SMase (1.0 U/ ml), P-fimbriated E. coli type 1-fimbriated E. coli, or nonfimbriated E. coli strains. Ceramide was extracted from cells harvested after 5, 10, 20, and 30 n'fin, and was phosphorylated in vitro using the diacylglycerol kinase assay. The product was separated by TLC, and ceramide 1-phosphate was quantitated by image analyzer. There was a rapid increase in the levels of free ceramide in cells exposed to SMase (151 _+ 35% at 20 min) and P-fimbriated E. coti (174 -+ 22% for E. coli AD110 and 125 + 18% for E. coli HB101/ Attaching Bacteria Elicit a Cytokine Response. The A498 cells were exposed to E. coli or PMA. Samples for cytokine measurements were withdrawn at 0, 2, 6, and 24 h. The kinetics of the cytokine responses are shown in Fig. 2 . The attaching E. coli strains had elicited an IL-6 response above background by 2 h, and the levels remained elevated at 6 and 24 h. The P-and type 1-fimbriated strains and PMA elicited the highest levels of IL-6. The nonfimbriated strains E. coli HB101 and E. coli AAEC were poor activators of IL-6.
SMase Elicits an IL-6 Response in the A498 Cells. The A498 cells were exposed to SMase (1.0-0.01 U/ml) and samples for IL-6 quantitation were withdrawn at 0, 2, 6, papAoltO at 20 min) (Fig. 3 A) . The type 1-fimbriated strain, and the nonfimbriated E. coli controls, stimulated lower levels of ceramide than the fimbriated strains (89 + 32% for E. coli PKL4, 104 -+ 13% for E. coli AAEC, and 101 + 15% for E. coli HB101 at 20 rain).
Phosphorylation of Ceramide in Cells Exposed to SMase or E. coli.
The in vivo phosphorylation of ceramide was studied in cells prelabeled with 32p i for 72 h, and then exposed to medium, SMase (1 U/ml), P-fimbriated E. coli, type 1-fimbriated E. coli, or nonfimbriated E. coli. Cells were harvested at 5, 10, 20, and 30 min, ceramide was extracted, and the amount of ceramide 1-phosphate was determined (Fig. 3 B) . The control cells had low levels of ceramide phosphorylation. Increased levels were observed in cells exposed to SMase and P-fimbriated E. coli for 20 min (223 • 21% for SMase, 218 • 30% for E. coli ADll0, 176 +--29% for E. coli HBlO1/papAD11o). SMase, the wild-type strain ADll0, and the P-fimbriated recombinant strain simulated higher ceramide 1-phosphate levels than the type 1-fimbriated strain and the nonfimbriated strains (133 + 18% for E. coti PKL4, 139 • 18% for E. coli AAEC, and 126 +--10% for E. coli HB101 at 20 rain).
Effects of Protein Kinase Inhibitors on Cytokine Responses. Phosphorylation of ceramide has been shown to involve serine/threonine protein kinases. The cytokine response to E. coli and PMA was analyzed in cells pretreated for 10 rain with staurosporine or K252a (inhibitors of serine/threonine-specific protein kinases) and genistein or tyrphostin 51 (inhibitors of tyrosine-specific protein kinases). The kinetics of the IL-6 response in the presence and absence of the inhibitors is shown in Fig. 4 . PMA-induced IL-6 responses were inhibited by staurosporine and K252a, but not by genistein or tyrphostin 51. The IL-6 response elicited by the P-firnbriated strains E. coli AD110 and E. coli HBlO1/papaDno were inhibited by staurosporine and K252a, whereas genistein and tyrphostin 51 had no effect. In contrast, the IL-6 response induced by the type 1-fimbriated strain E. coti PKL4 was decreased by genistein and tyrphostin 51 but was not affected by staurosporine or K252a. SMase Production by E. coli and A498 Cells. The SMase activity of the E. coli strains was analyzed in culture medium after filtration to remove bacterial cells. Low levels of acid SMase were detected in the bacteria before and after contact with the A498 cells. The SMase activity of the A498 cells was analyzed before and after exposure of the cells to E. coli. Both acid and neutral SMases were detected. A moderate increase in endogenous neutral SMase activity occurred after exposure to the bacteria.
LPS Is a Poor Activator of Epithelial Cell IL-6 Responses. The A498 cells were exposed to smooth LPS from S. typhimurium (0.1, 1.0, 10, and 100 ~g/ml). Samples for IL-6 quantitation were withdrawn after 0, 2, 6, and 24 h (Fig.  5) . The cells were negative for expression of surface CD-14 as determined by flow cytometry. Addition of normal human serum did not enhance the IL-6 response of the A498 cells to LPS.
Discussion
Ceramide has recently become recognized as a second messenger in the SM signal transduction pathway. It is released from SM after the action of SMase, an SM-specific form ofphospholipase C (26) . In cells, ceramide may influence growth and differentiation, regulate protein secretion, induce DNA fragmentation, and apoptosis, and enhance the synthesis and secretion of cytokines (14, (27) (28) (29) (30) (31) (32) . The molecular mechanisms that control these diverse actions are not yet understood. More is known about the extracellular agonists that cause the release of ceramide. The hydrolysis of SM occurs rapidly upon exposure of the cells to exogenous SMase or to agonists that activate endogenous SMases. Such agonists include TNF-ot, IL-113, IFN-% let,25-dihydroxyvitamin D3, and nerve growth factor (12) (13) (14) (33) (34) (35) (36) .
The results of this study add P-fimbriated E. coli bacteria to the list of agonists that release ceramide and suggest that this signal transduction pathway contributes to the bacterially induced cytokine response in epithelial cells.
Two approaches were used to study E. coli activation of the ceramide pathway in the A498 cells. The release of ceramide was studied in unlabeled cells and was quantitated by in vitro phosphorylation with diacylglycerol kinase (23) . With this assay, P-fimbriated E. coli and SMase were shown to stimulate the A498 cells to release ceramide. The phosphorylation of ceramide to ceramide 1-phosphate was quantitated in cells prelabeled with 32p i and then exposed to bacteria or SMase (22) . Extracted ceramide 1-phosphate was quantitiated after separation by TLC. With this assay, P-timbriated E. coli and SMase were shown to induce similar increases in ceramide /-phosphate levels. These methods were previously used to study the release and phosphorylation of ceramide in EL4 and HL-60 cells (14, 22) . The increases in free ceramide and in ceramide 1-phosphate observed in this study were of the same magnitude as the responses to other agonists in previous studies. The kinetics of the responses were also similar. This argues in favor of the bacteria as direct activators of the ceramide pathway and against a two-step process where the bacteria first acti-
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E. coli-induced Ceramide vate a mediator that, in turn, causes ceramide release. The A498 kidney epithelial cells do not make TNF in response to bacteria, and the IL-1 response is intracellular rather than secreted. Several intracellular targets for ceramide have been described. The ceramide-activated protein kinase (CAPK) belongs to the serine/threonine protein kinases (14) . Other targets include a serine/threonine--specific protein phosphatase and an isoform of protein kinase C (37, 38) . In this study, we examined the effects of serine/threonine protein kinase inhibitors on the cytokine response of the A498 cells using PMA, a known activator of these kinases, as a positive control. Staurosporine and K252a markedly reduced the IL-6 response to PMA and to P-fimbriated E. coli, suggesting that serine/threonine kinases are involved in the P fimbriae-induced cytokine response. In contrast, tyrosine kinase inhibitors (genistein and tyrphostin 51) had no effect on the IL-6 response.
There were interesting differences in the sensitivity to protein kinase inhibitors between P-and type 1-fimbriated E. coli. The P-and type 1-fimbriated E. coli strains attached avidly to A498 cells and induced higher IL-6 levels than isogenic, nonfirnhriated strains. Whereas the response to the P-fimbriated E. coli was blocked by inhibitors of serine/ threonine protein kinases, the IL-6 response to type 1-timbriated E. coIi was insensitive to these drugs. This suggested that the receptor specificity of the fimbriate and the nature of the cell surface receptor influenced the transmembrane signaling pathway leading to cytokine activation. The P-fimbriated E. coli strains induced the release and phosphorylation of ceramide, whereas type 1-fimbriated E. coli activated IL-6 production through other as yet unidentified signaling pathways. Type 1 fimbriae bind secreted or cellbound glycoproteins carrying terminal mannose residues (3). There is no evidence that type I fimbriae bind ceramide-containing receptors or that mannose residues recognized by the type I fimbrial lectin occur on glycolipids. The P-fimhriated E. coti, on the other hand, recognize the Galotl---)4Gal[3-containing oligosaccharides bound to ceramide in the outer leaflet of the lipid bilayer (2, 5, 6) . One might speculate that the P-fimbriated E. coli may induce the release of ceramide from the receptor glycolipid rather than from SM. P fimbriae and type 1 fimbriae may also differ in the ability to cause the release ofceramide from SM.
Exogenous SMase was shown to be a potent activator of IL-6 production and to release ceramide in the A498 cells. SMases are produced by a variety of bacterial species. The S. aureus SMase used in this study was previously shown to cleave SM and activate the release of ceramide in different cell types (11, 22) . Bacterial SMase production could therefore be a mechanism of ceramide release by the bacteria. The E. coli strains used in this study had low acid and no detectable neutral SMase activity. Bacterial SMase secretion or upregulation of cellular SMases therefore did not appear to explain the ceramide release and IL-6 response of the A498 cells. Activation of endogenous SMase leads to ceramide release in different cell types. Acid as well as neutral SMase activity were detected in the A498 cells. A moderate increase in neutral but not acid SMase activity was observed after exposure of the cells to E. coli. The possible differences in activation of endogenous SMases related to fimbrial expression need to be explored.
Ceramide and LPS were recently shown to have sufficient structural homology that LPS could replace ceramide as an activator ofserine/threonine protein kinases like CAPK (39) . The E. coli strains used in this study might thus activate cytokine production through a direct effect of LPS on CAPK. Purified LPS was, however, a poor activator of epithehal cell cytokine responses in this and in earlier studies, and the A498 cells lacked surface CD-14 (7, 40, 41) . The LPS-induced ceramide phosphorylation was shown to be CD-14 dependent (39).
Furthermore, if LPS were the principal activator of ceramide 1-phosphate production and IL-6 responses, the P-and type 1-fimbriated E. coli would be expected to deliver LPS to the surface with similar efficiency, The difference in ceramide release and sensitivity to serine/threonine kinase inhibitors between the P-and type 1-fimbriated strains suggested that P fimbriate contributed in an LPS-independent manner to the response or presented LPS differendy to the cells. Earlier studies have suggested that P fimbriae carry LPS at the tip, as an integral part of the G adhesin complex, adjacent to the receptor-binding domain (42) . This would provide the basis for a dual signal, through the glycohpid receptor and through LPS. Further studies are required to resolve these questions.
